Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Wine bottle
Non-zero rounding and prediction mode selection techniques in video encoding
Automated user interface adjustment
Wafer-level chip scale package
Once daily formulations of tetracyclines
System and method for leveraging independent innovation in entertainment content and graphics hardware
Over the counter medicinal container with surface ornamentation
  Randomly Featured Patents
Systems and methods for image handling and presentation
Multi-point video conference system and method
Screw device for high-adjusting a track span
Method for monitoring a communication system
Cationically polymerizable compositions containing photodecomposable aromatic iodonium salts
Multi-receptacle pyrotechnic cartridges and corresponding ammunition
Alignment layer including electrodeposited layer for liquid crystal display device and method for fabricating
Suppression of proteolytic activity by dysfunctional protease formation
Robust estimation of biodiesel blend ratio for alternative fuel combustion
Method and apparatus for transmitting high speed data by spectral decomposition of the signaling space